Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

5-O-(trans-9-octadecenoyl)-1--D-arabinofuranosyl cytosine

EU orphan designation number: EU/3/07/476   
Active ingredient: 5´-O-(trans-9´-octadecenoyl)-1-β-D-arabinofuranosyl cytosine
Indication: Treatment of acute myleoid leukaemia
Sponsor: Aqualis ASA
Sjølyst Plass 2, 0278 Oslo, Norge

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Centralised Orphan - Designation EMEA/OD/049/07 (2007)4336 of 14/09/2007
03/06/2008 Centralised Orphan - Change of address
04/04/2014 Centralised Orphan - Change of address